Advertisement
Regulatory News
Subscribe to Regulatory News

The Lead

CDC Scientist Kept Quiet About Flu Blunder

August 15, 2014 12:21 pm | by Mike Stobbe - AP Medical Writer - Associated Press | News | Comments

An investigation into a potentially dangerous blunder at a government lab found that a scientist kept silent about the accident and revealed it only after other employees noticed something fishy.               

WHO: Ebola Outbreak is a Public Health Emergency

August 8, 2014 3:21 am | by Maria Cheng - AP Medical Writer - Associated Press | News | Comments

The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an...

FDA Warns of Infection-causing Tattoo Inks

August 7, 2014 3:23 am | by Mary Clare Jalonick - Associated Press - Associated Press | News | Comments

Thinking about getting inked? Check the bottle first. The Food and Drug Administration is...

FDA to Start Regulating Lab-developed Tests

July 31, 2014 12:24 pm | by Matthew Perron - AP Health Writer - The Associated Press | News | Comments

The Food and Drug Administration says it will begin regulating laboratory-developed tests, a...

View Sample

FREE Email Newsletter

Is Europe Putting Cancer Research at Risk?

July 25, 2014 1:53 pm | News | Comments

The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.         

Head of Troubled CDC Anthrax Lab Resigns

July 23, 2014 1:20 pm | by The Associated Press | News | Comments

Health officials say that the head of the government lab which potentially exposed workers to live anthrax has resigned. Michael Farrell was head of the Centers for Disease Control and Prevention lab since 2009.            

300 Vials Labeled Influenza, Dengue Found at Lab

July 16, 2014 6:20 pm | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

The same federal scientist who recently found forgotten samples of smallpox at a federal lab also uncovered over 300 additional vials, many bearing the names of highly contagious viruses and bacteria.               

Advertisement

NIH Creates Network to Tackle Mysterious Diseases

July 1, 2014 4:20 pm | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

The government is expanding its "mystery disease" program, funding a network at six universities around the country to help diagnose patients with diseases so rare they've been told they're undiagnosable. The National Institutes of Health has evaluated hundreds of these cold-case patients in its campus research hospital as part of a pilot program since 2008. Demand is so great, there's a waiting list.  

FDA Prepping Long-awaited Plan to Reduce Salt

June 17, 2014 3:19 am | by Mary Clare Jalonick - Associated Press - Associated Press | News | Comments

Food companies and restaurants could soon face government pressure to make their foods less salty — a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke. The Food and Drug Administration is preparing to issue voluntary guidelines asking the food industry to lower sodium levels.

NIH Opens Research Hospital to Outside Scientists

March 13, 2014 2:44 pm | News | Comments

Ten projects that will enable non-government researchers to conduct clinical research at the National Institutes of Health’s Clinical Center in Bethesda, Md. were announced. Through these three-year, renewable awards of up to $500,000 per year, scientists from institutions across the United States will collaborate with government scientists in a highly specialized hospital setting.

'How Well Did You Sequence that Genome?' NIST, Consortium Partners Have Answer

February 26, 2014 1:43 pm | News | Comments

In December 2013, the U.S. Food and Drug Administration approved the first high-throughput DNA sequencer. Helping get the new device approved was another first: the initial use of a reference set of standard genotypes, or "coded blueprints" of a person's genetic traits.

US, 26 Countries Launch Effort to Fight Outbreaks

February 13, 2014 11:08 am | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

The U.S. and 26 other nations are announcing a new collaboration to prevent and fight outbreaks of dangerous infectious diseases before they spread around the globe. U.S. health officials say the Global Health Security Agenda is a priority because there are too many blind spots — countries that lack the health care necessary to sound the alarm when a new infection emerges.

Advertisement

NIST Categorizes Bio Scaffolds by Characteristic Cell Shapes

February 12, 2014 11:20 am | News | Comments

Getting in the right shape might be just as important in a biology lab as a gym. Shape is thought to play an important role in the effectiveness of cells grown to repair or replace damaged tissue in the body. To help design new structures that enable cells to "shape up," researchers at the NIST have come up with a way to measure, and more importantly, classify, the shapes cells tend to take in different environments.

US Lead in Science and Technology Shrinking

February 10, 2014 11:42 am | News | Comments

The United States' predominance in science and technology eroded further during the last decade, as several Asian nations—particularly China and South Korea—increased their innovation capacities. According to a report released by the National Science Board, the major Asian economies, taken together, now perform a larger share of global R&D than the U.S.

Durable End to AIDS Will Require HIV Vaccine Development

February 6, 2014 12:58 pm | Videos | Comments

Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in a more sustainable way, according to a new commentary from Anthony S. Fauci, MD, director of the NIAID.

NIH, Industry and Non-profits Join Forces to Speed Validation of Disease Targets

February 5, 2014 8:41 am | News | Comments

The National Institutes of Health, 10 biopharmaceutical companies and several nonprofit organizations today launched an unprecedented partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.

NIST Cell Membrane Model Studied as Future Diagnostic Tool

January 31, 2014 12:06 pm | News | Comments

Researchers at the National Institute of Standards and Technology (NIST) and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extraordinarily low concentrations.

Advertisement

The Massachusetts “Obamacare” Model Works

January 9, 2014 11:21 am | by Cynthia Fox | Articles | Comments

The partial model for Obamacare—Massachusetts’ near-universal health care program, adopted in 2006—resulted in measurably improved health. According to a study conducted by researchers from Harvard University and the University of Michigan—with help from the Centers for Disease Control (CDC)—the health of Massachusetts residents rose more in the first five years of the program than did the health of residents in other New England states.

Thermo Fisher Scientific Selling Life Science Businesses to GE

January 6, 2014 12:56 pm | News | Comments

Thermo Fisher Scientific announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion.   

New Drug Approvals from FDA Declined in 2013

January 3, 2014 10:50 am | by Matthew Perrone -- AP Health Writer -- Associated Press | News | Comments

The Food and Drug Administration approved 27 first-of-a-kind drugs in 2013, down from 39 new medications in 2012, which was a 15-year high.                                

23andMe Plays Nice

December 17, 2013 10:23 am | by Cynthia Fox | Articles | Comments

23andMe, the consumer genetics company halted by the FDA for ignoring repeated questions, is being conciliatory. The company offered raw gene data, and interpretative reports, to the general public on more than 240 diseases and traits until Dec. 5, when it announced it would cease taking new customers as a result of FDA action. However: “the company is now writing conciliatory letters to regulators,” says an insider.

FDA Seeks Tougher Rules on Antibacterial Soaps

December 16, 2013 11:19 am | by MATTHEW PERRONE - AP Health Writer, Associated Press | News | Comments

The federal government said Monday it has no evidence that antibacterial chemicals used in liquid soaps and washes help prevent the spread of germs, and it is reviewing research suggesting they may pose health risks.         

FDA Moves Toward Cutting Antibiotics in Meat

December 12, 2013 8:30 am | by MARY CLARE JALONICK - Associated Press - Associated Press | News | Comments

Citing a potential threat to public health, the Food and Drug Administration is taking steps toward phasing out the use of some antibiotics in animals processed for meat.                       

23andMe Will Follow FDA Order to Halt Test Sales

December 6, 2013 7:44 am | by The Associated Press | News | Comments

Genetic testing company 23andMe Inc. will comply with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review. The company said late Thursday that it will continue to provide ancestry-related information to customers and raw genetic data without interpretation.

US to Keep Ban on Paying Bone Marrow Donors

November 27, 2013 3:20 am | by LAURAN NEERGAARD - AP Medical Writer - Associated Press | News | Comments

The 1984 National Organ Transplantation Act that set the payment ban didn't just refer to solid organs — it included bone marrow transplants, too. Now, the government now has proposed a regulation to keep the ban intact by rewriting some legal definitions to clarify that it covers marrow-producing stem cells.

FDA Tells 23andMe to Halt Sales of Genetic Test

November 25, 2013 1:58 pm | by Matthew Perrone - AP Health Writer | News | Comments

The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.           

FDA OKs Four New Next-Gen Sequencing Devices

November 20, 2013 1:06 pm | News | Comments

The U.S. Food and Drug Administration allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). These instruments, reagents and test systems allow labs to sequence a patient’s DNA.

New Device Approved for Epilepsy Treatment

November 15, 2013 12:48 pm | News | Comments

The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.                                     

Top Neurologists Urge Obama: Map the Other Brain!

September 19, 2013 10:23 am | by Cynthia Fox | Articles | Comments

President Obama’s famous BRAIN mapping initiative is only 15%-of-a-brain initiative, said top NIH neuroscientist Douglas Fields and a growing chorus of others recently. The reason: while 85% of the brain is made of glial cells, stunningly, no governmental BRAIN publications, until recently, mentioned the word.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading